Efficacy of three BCG strains (Connaught, TICE and RIVM) with or without secondary resection (re-TUR) for intermediate/high-risk non-muscle-invasive bladder cancers: results from a retrospective single-institution cohort analysis

Francesco Del Giudice(Sapienza University of Rome), Ettore De Berardinis(Policlinico Umberto I), Alessandro Sciarra(Policlinico Umberto I), Michael L. Eisenberg(Palo Alto University), Martin Gross(Dartmouth–Hitchcock Medical Center), Simon Conti(Stanford University), Gian Maria Busetto(Sapienza University of Rome), Martina Maggi(Policlinico Umberto I), Stefano Salciccia(Policlinico Umberto I), Vittorio Canale(Sapienza University of Rome), Isabella Sperduti(San Gallicano Hospital), Benjamin I. Chung(Stanford Medicine), Rocco Simone Flammia(National Cancer Institute), Eila C. Skinner(Stanford University), Matteo Ferro(European Institute of Oncology)
Journal of Cancer Research and Clinical Oncology
March 6, 2021
Cited by 31


Related Papers